Adequan I.M. (Polysulfated Glycosaminoglycan Injection)

Adequan I.M. is a veterinary injectable medicine containing polysulfated glycosaminoglycan (PSGAG). It is approved in the United States for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses. Treatment should be prescribed and administered under the direction of a licensed veterinarian. According to the approved labeling, Adequan I.M. is intended to help manage joint disease as part of a comprehensive veterinary treatment plan.

Active Ingredient

• Polysulfated Glycosaminoglycan (PSGAG)

Polysulfated glycosaminoglycan is a semi-synthetic compound used in veterinary medicine to support joint health. The approved prescribing information describes its use in horses with degenerative or traumatic joint dysfunction affecting the carpal joint.

Approved Veterinary Use

According to the U.S. prescribing information, Adequan I.M. is indicated for:

• Non-infectious degenerative joint dysfunction
• Traumatic joint dysfunction
• Associated lameness of the carpal joint in horses

Veterinarians determine whether this medicine is appropriate after evaluating the horse’s condition and overall health.

Target Species

• Horses

Adequan I.M. is specifically approved for equine use according to the product labeling.

Product Features

• Prescription veterinary injectable medicine
• Contains polysulfated glycosaminoglycan
• Sterile intramuscular injection
• Manufactured under veterinary pharmaceutical quality standards
• Intended for professional veterinary use

Administration

Adequan I.M. should be administered only as directed by a licensed veterinarian. The dosage regimen, treatment schedule, and injection technique should follow the official prescribing information supplied with the product.

Storage

Store the product according to the manufacturer’s instructions. Keep the vial protected from conditions outside the recommended storage range and use it before the expiration date. Refer to the official product label for complete storage guidance.

Important Safety Information

Adequan I.M. is available only by veterinary prescription in many jurisdictions. It should be used according to the approved labeling and only under veterinary supervision. Your veterinarian should assess the horse before treatment and determine whether Adequan I.M. is appropriate. The prescribing information includes precautions, contraindications, and adverse reaction information that should be reviewed before use.

Frequently Asked Questions

What is Adequan I.M.?

Adequan I.M. is a prescription injectable veterinary medicine containing polysulfated glycosaminoglycan for the treatment of certain non-infectious joint conditions affecting the equine carpal joint.

Is Adequan I.M. a prescription medicine?

Yes. Adequan I.M. is a prescription veterinary medicine and should only be used under the direction of a licensed veterinarian.

Which animals is Adequan I.M. approved for?

According to the approved labeling, Adequan I.M. is approved for use in horses.

Can horse owners administer Adequan I.M. without veterinary advice?

The product should only be used according to a veterinarian’s prescription and instructions.

Adequan i.m Canine polysulfated glycosaminoglycan is administered two times a week for four weeks. The drug is injected intramuscularly to ensure it reaches the critical parts of the joint.

How adequan i.m Works

adequan i.m Canine polysulfated glycosaminoglycan is administered two times a week for four weeks. The drug is injected intramuscularly to ensure it reaches the critical parts of the joint. It goes to work in the joint in about two hours and stays in the joint for about three days.With Adequan Canine you should see signs of improvement within four weeks. Your dog may begin to act like the playful, active dog you remember.adequan i.m

Cautions:

adequan i.m Canine polysulfated glycosaminoglycan or PSGAG should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Possible side effects pain at injection site, diarrhea and abnormal bleeding were mild, transient and self-limiting. Safety studies of PSGAG in breeding, pregnant or lactating dogs have not been conducted.

 Storage Conditions:

Store at controlled room temperature up to 25°C (77°F) (See USP).

Frequently Asked Questions:

Q: What are the signs of canine arthritis?
It is important to note that arthritis occurs before clinical signs are shown. The beginning stages of this disease are not easily recognized. If your dog is suffering from arthritis, you will most likely see one or more of the following signs: lagging behind on walks, reluctance to walking, running, climbing stairs, jumping or playing. Additional signs may include: sluggishness, tiredness, low activity, reluctance to extend rear legs, aggressive or withdrawn behavior or other personality/behavioral changes.

Q: How do I know if my dog is at risk for this disease?
Canine arthritis does not discriminate. This disease can affect all breeds of dogs, but there are certain risk factors that you should be aware of, including: overweight, high activity levels for long periods of time, breed inherited traits, such as hip dysplasia, joint trauma, large breed and over the age of five.

Q: How does Adequan Canine polysulfated glycosaminoglycan or PSGAG work?